NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, siderocalin) is a small, robust protein, which is released into, and can be detected in, both urine and blood upon kidney tubular damage.
In recent years NGAL has been shown to be perhaps the earliest biomarker to respond to acute kidney injury in humans. After such injury, NGAL levels rise quickly and markedly in both urine and blood, showing a wide response range in comparison with other proposed biomarkers of kidney injury.
Because of this NGAL is a valuable biomarker for use in research and development, and we supply a complete range of NGAL products, including ELISAs, monoclonal antibodies and antigens for research and study purposes.
NGAL products from BioPorto: